[HTML][HTML] Risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma: a systematic review and meta-analysis
W Sun, X Lan, H Zhang, W Dong, Z Wang, L He… - PloS one, 2015 - journals.plos.org
Background Central lymph node metastasis (CLNM) is common in papillary thyroid
carcinoma (PTC). Prophylactic central lymph node dissection (PCLND) for patients with …
carcinoma (PTC). Prophylactic central lymph node dissection (PCLND) for patients with …
[HTML][HTML] The risk of central nodal metastasis based on prognostic factors of the differentiated thyroid carcinoma: a systematic review and meta-analysis study
LG Hafez, BE Elkomos, MAM El-Shafaei… - European Archives of …, 2023 - Springer
Background and aim Despite improving the 10-year disease-free-survival, prophylactic
central neck dissection (pCND) in differentiated thyroid carcinoma (DTC) should only be …
central neck dissection (pCND) in differentiated thyroid carcinoma (DTC) should only be …
Prophylactic lymph node dissection in clinically N0 differentiated thyroid carcinoma: example of personalized treatment
MV Deligiorgi, MI Panayiotidis… - Personalized Medicine, 2020 - Taylor & Francis
Considering the 'differentiated thyroid carcinoma (DTC) epidemic', the indolent nature of
DTC imposes a treatment paradigm shift toward elimination of recurrence. Lymph node …
DTC imposes a treatment paradigm shift toward elimination of recurrence. Lymph node …
Профилактическая центральная шейная лимфодиссекция как этап в лечении папиллярного рака щитовидной железы
МС Тигров, ЛП Яковлева… - Злокачественные …, 2024 - malignanttumors.org
Аннотация Актуальность: Вопрос о необходимости выполнения профилактической
центральной шейной лимфодиссекции в лечении локализованных форм …
центральной шейной лимфодиссекции в лечении локализованных форм …
Provera stražarskih limfnih nodusa kod diferentovanih tiroidnih karcinoma u odluci za selektivnu modifikovanu lateralnu disekciju vrata
IZ Marković - Универзитет у Београду, 2014 - nardus.mpn.gov.rs
Uvod: Diferentovani tiroidni karcinomi (DTK) čine do 90% svih tiroidnih maligniteta i najčešći
su primarni maligniteti endokrinog sistema. Njihova učestalost je u značajnom porastu u …
su primarni maligniteti endokrinog sistema. Njihova učestalost je u značajnom porastu u …